April Salama, M.d.

This study is testing whether adding an experimental drug called dapansutrile to the standard immunotherapy pembrolizumab can help patients with advanced melanoma whose cancer has stopped responding to PD-1 drugs alone. The trial has two parts: first finding the safest dose, then…